Alexander V. Sidorov

Alexander V. Sidorov

Auto-generated profile, based on publicly available information

Alexander V. Sidorov

I. Mechnikov Research Institute of Vaccines and Sera

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Fine Chemical Technologies
Verified
Journal Article
Open access
PDF file
MKM. O. Korotysheva
M. O. Korotysheva
APA. V. Pak
A. V. Pak
EFEvgeny Faizuloev
Evgeny Faizuloev
ASA. V. Sidorov
A. V. Sidorov
APAlexander Poddubikov
Alexander Poddubikov
VZV. V. Zverev
V. V. Zverev
Objectives. Evaluation of changes in the viral activity of influenza A/WSN/33 after complex knockdown of combinations of cellular genes FLT4, Nup98 and Nup205 in human lung cell culture A549. Methods. The work was carried out using the equipment of the Center for Collective Use of the I. Mechnikov Research Institute of Vaccines and Sera, Russia. The authors performed transfection of combinations of small interfering ribonucleic acid (siRNA) complexes that cause simultaneous disruption of the expression of cellular genes FLT4, Nup98, and Nup205. Within three days from the moment of transfection and infection, the supernatant fluid and cell lysate were taken for subsequent viral reproduction intensity determination using the titration method for cytopathic action. The dynamics of changes in the concentration of viral ribonucleic acid (vRNA) was determined by real-time reverse transcription polymerase chain reaction (real-time RT-PCR). The nonparametric Mann–Whitney test was used to calculate statistically significant differences between groups.Results. Using all of the combinations of siRNA complexes, cell viability did not decrease below the threshold level of 70%. In cells treated with complex FLT4.2 + Nup98.1 + Nup205 at the multiplicity of infection (MOI) equal to 0.1, a significant decrease in viral reproduction by 1.5 lg was noted on the first day in relation to nonspecific and viral controls. The use of siRNA complexes at MOI 0.01 resulted in a more pronounced antiviral effect. The viral titer in cells treated with siRNA complexes FLT4.2 + Nup98.1 and Nup98.1 + Nup205 decreased by 1.5 lg on the first day. In cells treated with complexes FLT4.2 + Nup205 and FLT4.2 + Nup98.1 + Nup205, it decreased by 1.8 and 2.0 lg on the first day and by 1.8 and 2.5 lg on the second day, respectively, in relation to nonspecific and viral controls. When conducting real-time RT-PCR, a significant decrease in the concentration of vRNA was noted. At MOI 0.1, a 295, 55, and 63-fold decrease in the viral load was observed with the use of siRNA complexes FLT4.2 + Nup98.1, Nup98.1 + Nup205, and FLT4.2 + Nup98.1 + Nup205, respectively. On the second day, a decrease in vRNA was also observed in cells treated with complex A. A 415-fold decrease in vRNA on the third day was noted in cells treated with complex FLT4.2 + Nup205. At MOI 0.01, the concentration of vRNA decreased 9.5 times when using complex B relative to nonspecific and viral control.Conclusions. The study showed a pronounced antiviral effect of siRNA combinations while simultaneously suppressing the activity of cellular genes (FLT4, Nup98, and Nup205), whose expression products are playing important role in the viral reproduction process, and obtained original designs of siRNA complexes. The results obtained are of great importance for the creation of emergence prophylactic and therapeutic drugs, whose action is based on the mechanism of RNA interference.

12 May 2022 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
VDV. V. Davydov
V. V. Davydov
ZSZhavoronok Serhey
Zhavoronok Serhey
TRT. A. Rogacheva
T. A. Rogacheva
TNT. P. Novik
T. P. Novik
GAG. I. Alatortseva
G. I. Alatortseva
VZV. V. Zverev
V. V. Zverev
Rationale. Hepatitis E (HE) is a zooanthroponosis. Domestic pigs are the main reservoir for hepatitis E virus (HEV) in the Republic of Belarus (RB). Considering the well-developed pig farming, there is a high risk of infection spread among the population; however, the scale of virus circulation and patterns of HE epidemiology in the above region are still insufficiently explored.The aim of the study is to assess HEV seroprevalence specific for the HE epidemic process in RB.Materials and methods. Serum samples (n = 2,784) collected from patients of infectious disease departments at hospitals (n = 1,669) and relatively healthy people (n = 1,114) from different RB regions were used to measure the activity of alanine aminotransferase (ALT) by a kinetic rate method as well as IgG antibodies to HEV by the enzyme-linked immunosorbent assay (ELISA).Results. In the group of healthy people, anti-HEV IgG were detected in 7.3% (95% CI, 5.8–9.0). In the group of patients with liver disorders, the detection frequency was significantly higher, reaching 11.2% (95% CI, 9.6–12.9). In the groups of healthy people and patients with elevated ALT levels, the HEV seroprevalence did not depend on their gender or the region of residence. The anti-HEV IgG detection frequency gradually increased among olderage patients and reached the peak levels (15.9% on average) in the over-64 age group.Conclusions. RB is characterized by intensive HEV circulation, while the HE epidemic process is characterized by a latent nature. The actual prevalence of HЕ seromarkers among the RB population exceeds the frequency of diagnosed cases, suggesting insufficient vigilance of healthcare workers towards HE and subclinical forms of infection in most of the patients.

9 April 2020 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
FNF. G. Nagieva
F. G. Nagieva
EBE. P. Barkova
E. P. Barkova
ALA. N. Lisakov
A. N. Lisakov
ASA. V. Sidorov
A. V. Sidorov
VZV. V. Zverev
V. V. Zverev
ASA. D. Stroeva
A. D. Stroeva
Введение. До настоящего времени принято считать, что инфекционность вируса Varicella Zoster (VZV – Varicella Zoster Virus) остается тесно связанной с клеткой, и вновь сформированный вирус не высвобождается в культуральную среду. Известно также, что VZV трудно выращивать в клеточных культурах, поскольку он медленно реплицируется, имеет ограниченный спектр чувствительных клеточных культур. Кроме того, изоляция VZV зависит от вида использованных клеточных культур, характера клинического материала, наличия жизнеспособного вируса и времени транспортировки. Цель работы. Изучение продукции инфекционного внеклеточного VZV с использованием различных клеточных культур. Материалы и методы. В работе использовали 8 различных клеточных культур, включая диплоидные клетки легких эмбриона человека и кожно-мышечную ткань эмбриона человека (КМ-27), а также перевиваемые клеточные линии человека и обезьян. В качестве клинических изолятов были использованы корочки от везикулярной сыпи, которые помещали в криопробирки с транспортной средой и транспортировали в жидком азоте. Инфекционность VZV оценивали на инфицированных клеточных культурах по реакции гемадсорбции со взвесью эритроцитов морских свинок или человека с нулевой группой крови и подтверждали в реакции непрямой иммунофлуоресценции с поликлональными сыворотками от людей, переболевших опоясывающим герпесом. Результаты. В работе было исследовано 27 клинических образцов в виде корочек от везикулярной сыпи от пациентов, заболевших ветряной оспой, и один образец от пациента в возрасте 63 лет в фазе обострения рецидивирующего опоясывающего герпеса. Первичное заражение клиническими изолятами проводили на штаммах диплоидных клеток легких эмбриона человека (ЛЭЧ-3) при низких температурах. Было установлено, что корочки от везикулярной сыпи, взятые от пациентов с 1 по 18 суток включительно с момента появления сыпи, вызывали на монослое клеток ЛЭЧ-3 цитопатическое действие в виде цитолиза клеток вокруг корочки. Специфичность ЦПД подтверждали ПЦР – РВ. Для оценки иммунных сывороток были приготовлены вирусные антигены на 7 клеточных линиях, зараженных лабораторным штаммом «Ellen» VZV (США). Была обнаружена высокая специфическая анти-VZV активность мышиных сывороток в ИФА при использовании в качестве твердофазного сорбента всех использованных лизатов инфицированных клеточных линий. В экспериментах по репродукции VZV было установлено, что внеклеточный вирус высвобождается в культуральную среду с 1-х суток с момента инфицирования чувствительных клеток, и инфекционность ВСЖ увеличивается в процессе дальнейшего культивирования.

18 May 2023 in Problems of Virology
Verified
Journal Article
Open access
PDF file
VMViktoriia Y. Momot
Viktoriia Y. Momot
APAnastasia V. Pak
Anastasia V. Pak
RSRoman V. Samoilikov
Roman V. Samoilikov
GPGeorge A. Pashkov
George A. Pashkov
GUGalina N. Usatova
Galina N. Usatova
VZVitaliy V. Zverev
Vitaliy V. Zverev
Introduction. Influenza is one of the most pressing global health problems. Despite the wide range of available anti-influenza drugs, the viral drug resistance is an increasing concern and requires the search for new approaches to overcome it. A promising solution is the development of drugs with action that is based on the inhibition of the activity of cellular genes through RNA interference. Aim. Evaluation in vivo of the preventive potential of miRNAs directed to the cellular genes FLT4, Nup98 and Nup205 against influenza infection. Materials and methods. The A/California/7/09 strain of influenza virus (H1N1) and BALB/c mice were used in the study. The administration of siRNA and experimental infection of animals were performed intranasally. The results of the experiment were analyzed using molecular genetic and virological methods. Results. The use of siRNA complexes Nup98.1 and Nup205.1 led to a significant decrease in viral reproduction and concentration of viral RNA on the 3rd day after infection. When two siRNA complexes (Nup98.1 and Nup205.1) were administered simultaneously, a significant decrease in viral titer and concentration of viral RNA was also noted compared with the control groups. Conclusions. The use of siRNAs in vivo can lead to an antiviral effect when the activity of single or several cellular genes is suppressed. The results indicate that the use of siRNAs targeting the cellular genes whose expression products are involved in viral reproduction is one of the promising methods for the prevention and treatment of not only influenza, but also other respiratory infections.

2 September 2020 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
ФНФирая Галиевна Нагиева
Фирая Галиевна Нагиева
ЕБЕлена Петровна Баркова
Елена Петровна Баркова
АСАлександра Дмитриевна Строева
Александра Дмитриевна Строева
АСАлександр Викторович Сидоров
Александр Викторович Сидоров
ВЗВиталий Васильевич Зверев
Виталий Васильевич Зверев
Introduction. Chickenpox poses a significant public health concern due to its worldwide occurrence, a substantial probability of severe clinical progression, development of complications that can lead to a fatal outcome. Routine vaccination is the only way to prevent the disease. The purpose of this study was to assess the attenuation of cold-adapted (CA) candidate virus strains of Varicella zoster and Herpes zoster by using traditional and new methods.Materials and methods. The study was performed on strains of diploid cells from human embryonic lung and musculocutaneous tissue, primary and diploid cells of guinea pig fetal fibroblasts. Two clinical isolates of the virus were obtained — from a child with chickenpox and from an adult during the reactivation of shingles. The vOka vaccine strain and Ellen strain, a laboratory strain, were used as a control. The viral infectivity was measured by using a sensitive limiting dilution assay. The virulence was measured through the analysis of chick embryo chorioallantoic membranes infected with the Varicella zoster virus.Results. The clinical isolates were sub-cultured at lower temperatures, put through comparative tests and checked for presence of attenuation biomarkers. It was found that vFiraVax, a Varicella zoster virus strain, and vZelVax, a Herpes zoster virus strain were temperature-sensitive and cold-adaptable, but they lacked virulence. Attenuated CA virus strains induced lower expression of IFN-α and IFN-γ receptors on human mononuclear cells as compared to their parental variants.Conclusion. We created and assessed two candidate vaccine strains through attenuation of clinical isolates.

15 December 2024 in Problems of Virology
Verified
Journal Article
Open access
PDF file
FNFiraya G. Nagieva
Firaya G. Nagieva
EBElena P Barkova
Elena P Barkova
OKOlga S. Kharchenko
Olga S. Kharchenko
ASAlexander V. Sidorov
Alexander V. Sidorov
GAGalina I. Alatortseva
Galina I. Alatortseva
VZVitaly V. Zverev
Vitaly V. Zverev
Introduction. Varicella-Zoster virus (VZV) is a highly contagious alpha-herpes virus. The diagnosis of chickenpox remains a difficult task especially in cases of breakthrough chickenpox, so the development of reliable laboratory tests is necessary. The simplest and most sensitive serological test for detecting antibodies in human and animal sera is the passive hemagglutination reaction (PHAR). The aim. To develop of a simple, highly sensitive and specific serological tests for the detection of antibodies to VZV in human and animal blood sera. Materials and methods. Human and animal cell cultures; various strains of VZV; human and animal immune sera; monoclonal antibody to VZV glycoprotein (GP) E. Formalin-treated erythrocytes of sheep, chickens and goats, sensibilised with GP of VZV from a virus-containing supernatant were used for PHAR. Results. Cell cultures with the maximum cytopathic effect at VZV infection were selected. A simple original method for obtaining virus-specific VZV GPs using lectins has been developed. Purified GPs were obtained by their elution from sheep erythrocytes after adsorption. The activity of VZV GP was confirmed in PHAR by an antibody diagnostic assay using formalin-treated sheep erythrocytes sensibilised using monoclonal antibodies to GP E of the “vOka” VZV strain (USA). Using GPs from different VZV strains, PHAR test and GP-based enzyme-linked immunosorbent assay (gpELISA) have been developed to detect antibodies in human and animal immune sera. These tests have high sensitivity, specificity and lack of cross-reactivity. Conclusion. A highly specific, sensitive and reproducible tests for the detection of antibodies to VZV have been developed.